[HTML][HTML] Metabolic syndrome: risk factors, diagnosis, pathogenesis, and management with natural approaches
SM Mohamed, MA Shalaby, RA El-Shiekh… - Food Chemistry …, 2023 - Elsevier
Metabolic syndrome (MetS) is a bunch of metabolic defects comprising hypertension, insulin
resistance, visceral obesity, fatty liver, and atherogenic cardiovascular diseases. Lifestyle …
resistance, visceral obesity, fatty liver, and atherogenic cardiovascular diseases. Lifestyle …
Obesity, metabolic syndrome, and cancer: pathophysiological and therapeutic associations
Overweight, obesity, and metabolic syndrome (MetS) have become epidemic conditions
affecting 39%, 13%, and 20% of the population respectively. The aim of this article is to …
affecting 39%, 13%, and 20% of the population respectively. The aim of this article is to …
[HTML][HTML] Diabetes and cancer: risk, challenges, management and outcomes
Simple Summary Diabetes mellitus is a common disease in patients with cancer. It is a risk
factor for certain cancers such as pancreatic, liver, colon, breast, and endometrial cancer …
factor for certain cancers such as pancreatic, liver, colon, breast, and endometrial cancer …
[HTML][HTML] Epigallocatechin gallate: a review of its beneficial properties to prevent metabolic syndrome
Obesity and being overweight are linked with a cluster of metabolic and vascular disorders
that have been termed the metabolic syndrome. This syndrome promotes the incidence of …
that have been termed the metabolic syndrome. This syndrome promotes the incidence of …
[HTML][HTML] Adipocyte and lipid metabolism in cancer drug resistance
Y Cao - The Journal of clinical investigation, 2019 - Am Soc Clin Investig
Development of novel and effective therapeutics for treating various cancers is probably the
most congested and challenging enterprise of pharmaceutical companies. Diverse drugs …
most congested and challenging enterprise of pharmaceutical companies. Diverse drugs …
Association between metabolic syndrome and cancer
M Uzunlulu, O Telci Caklili, A Oguz - Annals of Nutrition and Metabolism, 2016 - karger.com
Growing data show the association of metabolic syndrome (MetS) or its components with
cancer development and cancer-related mortality. It is suggested that in MetS and cancer …
cancer development and cancer-related mortality. It is suggested that in MetS and cancer …
[HTML][HTML] Possible mechanisms of green tea and its constituents against cancer
Y Shirakami, M Shimizu - Molecules, 2018 - mdpi.com
A number of epidemiological, clinical, and experimental researches have indicated that
administration of green tea appears to have anti-cancer activity. According to findings of …
administration of green tea appears to have anti-cancer activity. According to findings of …
Shared risk factors for cardiovascular disease and cancer: implications for preventive health and clinical care in oncology patients
CB Johnson, MK Davis, A Law, J Sulpher - Canadian Journal of Cardiology, 2016 - Elsevier
The cardiovascular toxicity of cancer therapy has raised awareness of the importance of
heart disease in cancer care among oncologists and cardiologists, leading to the new …
heart disease in cancer care among oncologists and cardiologists, leading to the new …
[HTML][HTML] Metabolic syndrome and cancer risk: the role of xanthine oxidoreductase
Obesity and related pathologies such as diabetes and metabolic syndrome are associated
with chronic inflammation and cancer. The serum level of xanthine oxidoreductase (XOR) is …
with chronic inflammation and cancer. The serum level of xanthine oxidoreductase (XOR) is …
From obesity to cancer: a review on proposed mechanisms
Nowadays, obesity is considered as a serious and growing global health problem. It is
documented that the overweight and obesity are major risk factors for a series of …
documented that the overweight and obesity are major risk factors for a series of …